Pseudomonas aeruginosa isolates recovered from clinical and environmental samples in Buea, Cameroon: Current status on biotyping and antibiogram

Tropical Medicine and International Health

Volumn 10, Issue 1, 2005, Pages 74-81

  Ndip, R N ^a   Dilonga, H M ^a   Ndip, L M ^a   Akoachere, J F K ^a   Akenji, T Nkuo ^a  

^a UNIVERSITY OF BUEA   (Cameroon)

Author keywords

Antibiogram; Biotypes; Clinical specimens; Environmental samples; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; NETILMICIN; TETRACYCLINE; TOBRAMYCIN;

BIOTYPE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BIOTYPE; CAMEROON; CHEMICAL ANALYSIS; DEVELOPING COUNTRY; EPIDEMIOLOGICAL DATA; HEALTH CARE FACILITY; LABORATORY DIAGNOSIS; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; PREVALENCE; PSEUDOMONAS AERUGINOSA; SAMPLING; SPUTUM CULTURE; STATISTICAL SIGNIFICANCE; URINE CULTURE; WOUND;

AGED; BACTERIAL TYPING TECHNIQUES; CAMEROON; DEVELOPING COUNTRIES; ENVIRONMENTAL MICROBIOLOGY; EQUIPMENT CONTAMINATION; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 13244255745     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2004.01353.x     Document Type: Article

References (39)

1. Abimbola KA, Obi CL, Alabi SA, Olukoya DK & Ndip RN (1993) Current status on biotyping, antibiogram and plasmid profiles of Escherichia coli isolates. East African Medical Journal 70, 207-210.
2. Aka J, Dosso M & Michel G (1987) Antibiotic resistance of Pseudomonas aeruginosa: a fact and problem at the University Hospital Center of Cocody (Abidjan). Medecine Tropicale 47, 53-59.
3. Akoachere J-FTK, Ndip RN, Chenwi EB, Ndip LM, Njock TE & Anong DN (2002) Antibacterial effect of Zinziber officinale and Garcinia kola on respiratory tract pathogens. East African Medical Journal 79, 588-591.
4. Balows AL, Hausler WJ Jr, Hermann LK, Isenberg HD & Shadomy HJ (1991) Typing methods for epidemiological investigation. In: Manual of Clinical Microbiology, 5th edn. (eds Hausler WJ, Hermann LK, Isenberg HD, Shadomy HJ) American Society for Microbiology, Washington, DC, pp. 171-179.
5. Baron S (ed) (1986) Pseudomonas. In: Medical Microbiology, 2nd edn. Addison-Wesley Publishing Company, Inc., California, USA, pp. 507-513.
6. Bauer AW, Kirby MM, Sharis JL, Turck M (1966) Antibiotic susceptibility testing by a standard single disk method. American Journal of Clinical Pathology 45, 493-496.
7. Berrouane FY, McNutt L, Buschellman BJ et al. (2000) Outbreak of severe P. aeruginosa infection caused by contaminated drains in a whirlpool bathtubs. Clinical Infectious Diseases 31, 1331-1337.
8. Bouza E, Garcia-Garrote F, Cercenado M & Diaz MS (1999) Pseudomonas aeruginosa: Survey of resistance in 136 hospitals in Spain. Antimicrobial Agents and Chemotherapy 43, 981-982.
9. Cheesbrough M (ed) (2000) Pseudomonas and related organisms; Biochemical test to identify bacteria; Antimicrobial susceptibility testing. In: District Laboratory Practice in Tropical Countries Part II. Low price edition 2000. Cambridge University Press, Cambridge, pp. 193-194; 63-70; 132-143.
10. Doern GV, Pfaller MA & Erik LM (2002) Modification of dienes mutual inhibition test for epidemiological characterisation of P. aeruginosa isolates. Journal of Clinical Microbiology 40, 4285-4288.
11. DuBois V, Arpin C, Melon M et al. (2001) Nosocomial outbreak due to a multi-resistance strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of β-lactam resistance. Journal of Clinical Microbiology 39, 2072-2078.
12. Estahbanati KH, Kashani PP & Ganagtpisheh F (2002) Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics. Burns 28, 340-348.
13. Forbes BA, Sahm DF & Weissfeld AS (1998) Pseudomonas, Burkholderia and similar organisms. In: Bailey and Scott's Diagnostic Microbiology, 10th edn. (eds Roche J, Parker SJ, MacAdam L) Mosby Inc., St. Louis, USA, pp. 448-451.
14. Freitas AL & Barth AL (2004) Typing of Pseudomonas aeruginosa from hospitalised patients. Comparison of susceptibility and biochemical profiles with genotypes. Brazilian Journal of Medicine, Biology and Research 37, 77-82
15. Gales AC, Jones RN, Turnidge J, Rennie R & Ramphal R (2001) Characterisation of Pseudomonas aeruginosa isolates: occurrence rate, antimicrobial susceptibility pattern and molecular typing in the Global SENTRY antimicrobial surveillance program 1997-1999. Clinical Infectious Disease 32, S146-155.
16. Gallego L, Pujana I, Canduela MJ & Cisterna R (2000) Specific and rapid identification of multiple-antibiotic resistance Pseudomonas aeruginosa clones isolated in an intensive care unit. Diagnostic Microbiology and Infectious Disease 36, 65-68.
17. Harbour C, Anthony M, Rose B et al. (2002) Genetic analysis of Pseudomonas aeru ginosa isolates from the sputa of Australian adult cystic fibrosis patients. Journal of Clinical Microbiology 40, 2772-2778.
18. Hernández J, Ferrús MA, Hernández M & Owen RJ (1997) Arbitrary primed PCR fingerprint and serotyping of clinical Pseudomonas aeruginosa strains. FEMS Immunology and Medical Microbiology 17, 37-47.
19. Higaki M, Chida T, Takano H & Nakaya R (1990) Cytotoxic components of Klebsiella oxytoca on Hep-2 cells. Microbiology and Immunology 34, 147-151.
20. Jawetz E, Melnick JL, Adelberg EA, Brooks GF, Butel SJ, Ornston LN (1991) Pseudomonads, Acinetobacter and uncommon gram-negative bacteria. In: Review of Medical Microbiology, 19th edn. (ed. Jawetz E) Appleton and Langue Publishing Prentice Hall, Los Altos, California, USA, pp. 224-229.
21. Joklik KW, Willet PH, Amos BD & Catherine MW (1992) Pseudomonas. In: Zinser Microbiology, 20th edn. (eds Joklik KW, Willet PH, Amos BD, Wilfred CM) Durham, Nolwalk, USA, pp. 576-583.
22. Kamoun A, Ben Hassen A, Fendri C & Ben Redjeb S (1992) Pseudomonas aeruginosa and beta-lactam resistance phenotype (Tunisia 1989-1990). Archives of Institute Pasteur Tunis 69, 263-271.
23. Köhler T, Delden CV, Curty LK, Hamrehpour MM & Pechere JC (2001) Over expression of the MexEF-OprN multi-drug efflux system affects cell-to-cell signalling in Pseudomonas aeruginosa. Journal of Bacteriology 183, 5213-5222.
24. Koneman EW, Allen DS, Janda MW, Schrenckenberger CP & Washington C (1992) Non-fermentative gram-negative bacilli. In: Color Atlas and Textbook of Diagnostic Microbiology, 4th edn. J.B. Lippincott Company, Philadelphia, PA, pp. 185-252.
25. Livrelli V, De Champs C, Di Martino P, Darfeuille-Michaud A, Forestier C & Joly B (1996) Adhesive properties and antibiotic resistance of Klebsiella, Enterobacter, and Serratta clinical isolates involved in nosocomial infections. Journal of Clinical Microbiology 34, 1963-1969.
26. Luh K, Hsueh P, Teng L, Yang P, Chen Y & Ho S (1998) Persistence of multi-drug resistance Pseudomonas aeruginosa clone in an intensive care burn unit. Journal of Clinical Microbiology 36, 1347-1351.
27. Moreira BM, Pellegrino FLPC, Teixeira LM et al. (2002) Occurrence of multi-drug-resistance Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil. Journal of Clinical Microbiology 40, 2420-2424.
28. National Committee for Clinical Laboratory Standards (2000) Performance Standards for Antimicrobial Disk Susceptibility Testing. Document M100-S9. National Committee for Clinical Laboratory Standards, Wayne, PA.
29. Ndip RN, Titanji VPK, Akenji TN, Mutanga AM, Mbacham WF & Ndip LM (2001) Antibiogram of Klebsiella pneumoniae isolates from Buea, Cameroon. Central African Journal of Medicine 47, 173-176.
30. Ndip RN, Aroke G, Mbacham W, Ndip LM & Titanji VP (2003) Antibiogram and plasmid profiles of Neisseria gonorrhoeae isolates from Cameroon: useful tools for epidemiological survey. African Journal of Reproductive Health 7, 100-105.
31. Pagani L, Migliavacca R, Docquier JD et al. (2002) Simple microdilution test for detection of metallo-β-lactamase production in Pseudomonas aeruginosa. Journal of Clinical Microbiology 40, 4388-4390.
32. Pitout JDD, Thomson KS, Hanson ND, Ehrdardit AF, Moland ES & Sanders CC (1998) B-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis isolates recovered in South Africa. Antimicrobial Agents and Chemotherapy 42, 1350-1354.
33. Podschum R & Ullman U (1998) Klebsiella species as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenecity factors. Clinical Microbiology Reviews 11, 589-603.
34. Poirel L, Weldhagen GF, Naas T, De Champs C, Dove, MG & Nordmann P (2001) GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrobial Agents and Chemotherapy 45, 2598-2603.
35. Poirel L, Weldhagen GF, De Champs C & Nordmann P (2002) A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum beta-lactamase GES-2 in South Africa. Journal of Antimicrobial Chemotherapy 49, 561-565.
36. Rotimi VO, Onyenefa PI, Banjo TO, Ogunsola FT & Adenuga A (1994) Significance of antibiotics resistance among clinical bacterial isolates in Lagos. West African Journal of Medicine 13, 81-86.
37. Todar K (2002). Pseudomonas aeruginosa. Todar's Online Textbook of Bacteriology, http://testbookofbacteriology.net/pseudomonas.html.
38. Volk WA, Benjamin DC, Kadner, RJ & Parson JT (1991) Enteric and related gram-negative organisms. In: Essentials of Medical Microbiology, 4th edn. (eds Winter R, Bellus MA, Mintzer J) Lippincott Company, New York, USA, pp. 388-414.
39. Worgall S, Kikuchi T, Singh R, Martushova K, Leande L & Crystal RG (2001) Protection against pulmonary infection with Pseudomonas aeruginosa following immunisation with P. aeruginosa-pulsed dendritic cells. Infection and Immunity 69, 4521-4527.